ABSTRACT BACKGROUND: Although the prognosis of differentiated thyroid carcinoma
(DTC) therapy is considered excellent over time, some cases have a poorer prognosis and …

Background and aims Differentiated thyroid carcinoma (DTC) is the most common endocrine
tumor. DTC has a good prognosis and survival rates are higher than 85%. The aim of our …

Background The study evaluates clinical presentation and outcome of differentiated thyroid
cancer (DTC) on a large series of patients homogeneously managed. Patients and methods …

Background: Survival studies in differentiated thyroid carcinoma (DTC) may be biased
because they have been performed in heterogeneous populations. In addition, specific …

Objective Prognostic factors of differentiated thyroid carcinoma (DTC) are analyzed to justify
the diagnostic and therapeutic modalities of DTC in current practice. Methods Patients …

Background: Trends in the epidemiological profiles of differentiated thyroid cancer (DTC)
have shifted the disease spectrum. This study aimed to evaluate the recurrence rates and …

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Background Differentiated thyroid cancer (DTC) is generally associated with a favorable
prognosis. Its treatment requires surgery, selective use of radioiodine and levothyroxine, and …

Objectives/Hypothesis The incidence of thyroid carcinoma is rising. Few studies have
examined patient characteristics that influence survival when adjusting for treatment and …

DOMINGUEZ, José Miguel et al. Riesgo de recurrencia en cáncer diferenciado de tiroides:
escala MINSAL. Rev. méd. Chile [online]. 2018, vol. 146, n. 3, pp. 282-289. ISSN 0034 …